Production of therapeutic glycoproteins in glycoengineered plant: old farm for new crops
Current Opinion in Biotechnology · 2024-06 · 87 · 103145
DOI: 10.1016/j.copbio.2024.103145 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Biotechnology, 2024-06. Verfasst von Mu-Rong Kao und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan; Division of Glycoscience, Department of Chemistry, School of Engi…. Hauptthemen laut MEDLINE: Glycoproteins, Recombinant Proteins, Plants, Genetically Modified. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Ministry of Science and Technology, Taiwan, KTH Royal Institute of Technology.
Abstract (Originalsprache)
Plant-based expression systems have emerged as promising avenues for the production of recombinant N-linked glycoproteins. This review offers insights into the evolution and progress of plant glycoengineering. It delves into the distinctive features of plant-derived N-glycans, the diverse range of plant hosts employed for glycoprotein synthesis, and the advancements in glycoengineering strategies aimed at generating glycoproteins with N-glycan structures akin to those produced in mammalian cell lines. Furthermore, alternative strategies for augmenting glycoengineering efforts and the current spectrum of applications for plant-produced N-glycan recombinant proteins are examined, underscoring their potential significance in biopharmaceutical manufacturing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan; Division of Glycoscience, Department of Chemistry, School of Engineering Sciences in Chemistry, Biotechnology and Health, Royal Institu…
Förderung
- National Science and Technology Council
- Ministry of Science and Technology, Taiwan
- KTH Royal Institute of Technology
Zitieren
APA
Kao, M. R., Karmarkar Saldivar, R., & Hsieh, Y. S. Y. (2024). Production of therapeutic glycoproteins in glycoengineered plant: old farm for new crops. Current Opinion in Biotechnology, 87, 103145. https://doi.org/10.1016/j.copbio.2024.103145
Vancouver
Kao MR, Karmarkar Saldivar R, Hsieh YSY. Production of therapeutic glycoproteins in glycoengineered plant: old farm for new crops. Current Opinion in Biotechnology. 2024;87:103145. doi:10.1016/j.copbio.2024.103145
BibTeX
@article{Kao2024,
author = {Kao, Mu-Rong and Karmarkar Saldivar, Rebecka and Hsieh, Yves S Y},
title = {Production of therapeutic glycoproteins in glycoengineered plant: old farm for new crops},
journal = {Current Opinion in Biotechnology},
year = {2024},
volume = {87},
pages = {103145},
doi = {10.1016/j.copbio.2024.103145}
}
EUVIMED